Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BCKDK | O14874 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156931 | 0.85 | CYP2A6 (0.69) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL27610613 | 0.82 | CYP2A6 (0.44) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL2094712 | 0.81 | CYP2A6 (0.58) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL2089676 | 0.81 | CYP2A6 (0.50) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL5446885 | 0.81 | CYP2A6 (0.50) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL2095039 | 0.81 | CYP2A6 (0.46) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 | |
| SCHEMBL7965487 | 0.80 | KEAP1 (0.77) | CYP2A6KEAP1NFE2L2CA2MAPT | |
| SCHEMBL10222343 | 0.79 | MTNR1A (0.48) | CYP2A6CA2SMN1; SMN2MAPTLMNA | |
| SCHEMBL10989414 | 0.79 | KEAP1 (0.55) | CYP2A6KEAP1NFE2L2CA2MAPT | |
| SCHEMBL10424393 | 0.79 | CYP2A6 (0.56) | CYP2A6KEAP1NFE2L2CA2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |